openPR Logo
Press release

Want to know positive clinical results of Interleukin 8 Inhibitors? | Top Players DOMPE FARMACEUTICI - S.P.A., Dompé, Bristol-Myers Squibb

06-20-2019 08:25 AM CET | Health & Medicine

Press release from: Interleukin 8 Inhibitors Therapeutics -Pharma Proff

Interleukin 8 is a chemokine produced by various immune cells. They promote angiogenesis, proliferation and development of cancerous cells. The other diseases which are associated with interleukin 8 are depression, schizophrenia, bipolar disorder, migraine, Alzheimer’s disease, colitis, rheumatoid arthritis, multiple sclerosis, asthma, allergic rhinitis, psoriasis, eczema and others.

Download the sample report @ https://www.pharmaproff.com/request-sample/1203

Interleukin 8 inhibitors therapies have shown improvements as anti-CXCL8 signalling inhibitors for the treatment of various diseases, including cancer and inflammatory diseases. Studies demonstrated that interleukin 8 can be indirectly targeted by mitogen activated protein kinase (MAPK) inhibitors, phosphatidylinositol-3-kinase (PI3K)/AKT inhibitors, and NF-κB inhibitors while direct targeting can be done by CXCL8 neutralizing antibodies, and other drug therapies such as Reparixin. Potent effects of interleukin 8 inhibitors therapeutics as chemo-modulators and anti-angiogenics are expected to treat various tumors.

Get the detailed analysis @ https://www.pharmaproff.com/report/interleukin-8-inhibitors

Bristol-Myers Squibb Company is in the process of developing HuMax-IL8 as a biologic which acts as an interleukin 8 inhibitor for the treatment of solid tumors. Dompé farmaceutici S.p.A. is another key player has interleukin 8 inhibitor pipeline therapeutics.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1203

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licencing, grants, technology and others.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Want to know positive clinical results of Interleukin 8 Inhibitors? | Top Players DOMPE FARMACEUTICI - S.P.A., Dompé, Bristol-Myers Squibb here

News-ID: 1782041 • Views:

More Releases for CXCL8

2022-2028 CXCL8 (Chemokine Protein) Market | Detailed Report
The CXCL8 (Chemokine Protein) research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the CXCL8 (Chemokine Protein) research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force. Download FREE Sample Report
CXCL8 Market 2019 | Worldwide Forecast 2025 | Major Players - Aviva Systems Biol …
CXCL8 Marketresearch report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/105776 UpMarketResearch offers a latest published report on “Global CXCL8 Market Analysis and Forecast 2019 - 2025” delivering key insights and providing a competitive advantage to clients through a
Interleukin 8 Inhibitors Therapeutics - Pipeline Analysis 2019 Designations, Col …
Interleukin 8 is a chemokine produced by various immune cells. They promote angiogenesis, proliferation and development of cancerous cells. The other diseases which are associated with interleukin 8 are depression, schizophrenia, bipolar disorder, migraine, Alzheimer’s disease, colitis, rheumatoid arthritis, multiple sclerosis, asthma, allergic rhinitis, psoriasis, eczema and others. Download the sample report @ https://www.pharmaproff.com/request-sample/1203 Interleukin 8 inhibitors therapies have shown improvements as anti-CXCL8 signalling inhibitors for the treatment of various diseases, including
Pipeline Assessment on Global CXCL8 Market Considering Companies, Scope, Ongoing …
The Market Research Hub’s report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for CXCL8 market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers, and other people who are in need of